Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -70,279 | -98,942 | -89,380 | -91,579 | -54,780 |
| Depreciation Amortization | 7,712 | 7,648 | 7,043 | 3,819 | 728 |
| Accounts receivable | -1,785 | 0 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -1,460 | -353 | -856 | 3,581 | 2,682 |
| Other Working Capital | -24,627 | 11,799 | -10,551 | 114,824 | 3,140 |
| Other Operating Activity | 13,919 | 16,994 | 18,221 | 13,276 | 7,386 |
| Operating Cash Flow | $-76,520 | $-62,854 | $-75,523 | $43,921 | $-40,844 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,002 | -1,937 | -4,676 | -21,492 | -4,362 |
| Purchase Of Investment | -46,420 | -21,832 | -97,934 | -290,594 | -267,761 |
| Sale Of Investment | 16,904 | 136,087 | 158,312 | 246,494 | 136,390 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -1,400 |
| Investing Cash Flow | $-30,518 | $112,318 | $55,702 | $-65,592 | $-137,133 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 25,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | N/A | -2,600 |
| Common Stock Issued | 61,656 | 465 | 116 | 2,138 | 140,349 |
| Common Stock Repurchased | N/A | -197 | -33 | 0 | N/A |
| Other Financing Activity | -425 | 0 | 0 | 0 | -24 |
| Financing Cash Flow | $86,231 | $268 | $83 | $2,138 | $137,725 |
| Beginning Cash Position | 85,933 | 36,201 | 55,939 | 75,472 | 114,185 |
| End Cash Position | 65,126 | 85,933 | 36,201 | 55,939 | 73,933 |
| Net Cash Flow | $-20,807 | $49,732 | $-19,738 | $-19,533 | $-40,252 |
| Free Cash Flow | |||||
| Operating Cash Flow | -76,520 | -62,854 | -75,523 | 43,921 | -40,844 |
| Capital Expenditure | -1,002 | -1,937 | -4,676 | -21,492 | -4,362 |
| Free Cash Flow | -77,522 | -64,791 | -80,199 | 22,429 | -45,206 |